TW200716104A - Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors - Google Patents

Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors

Info

Publication number
TW200716104A
TW200716104A TW095118171A TW95118171A TW200716104A TW 200716104 A TW200716104 A TW 200716104A TW 095118171 A TW095118171 A TW 095118171A TW 95118171 A TW95118171 A TW 95118171A TW 200716104 A TW200716104 A TW 200716104A
Authority
TW
Taiwan
Prior art keywords
class
tricyclic
penems
alkylidene
lactam antibiotics
Prior art date
Application number
TW095118171A
Other languages
English (en)
Chinese (zh)
Inventor
Tarek Suhayl Mansour
Aranapakam Mudumbai Venkatesan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200716104A publication Critical patent/TW200716104A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW095118171A 2005-06-01 2006-05-22 Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors TW200716104A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68622105P 2005-06-01 2005-06-01

Publications (1)

Publication Number Publication Date
TW200716104A true TW200716104A (en) 2007-05-01

Family

ID=37836305

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095118171A TW200716104A (en) 2005-06-01 2006-05-22 Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors

Country Status (14)

Country Link
US (1) US20060276446A1 (https=)
EP (1) EP1885358A2 (https=)
JP (1) JP2008542376A (https=)
CN (1) CN101189010A (https=)
AR (1) AR054467A1 (https=)
AU (1) AU2006287938A1 (https=)
BR (1) BRPI0611491A2 (https=)
CA (1) CA2610478A1 (https=)
GT (1) GT200600235A (https=)
MX (1) MX2007015173A (https=)
PE (1) PE20070010A1 (https=)
SV (1) SV2007002555A (https=)
TW (1) TW200716104A (https=)
WO (1) WO2007030166A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
US8524304B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US8512789B2 (en) * 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
JP2012121809A (ja) * 2009-02-26 2012-06-28 Eisai R & D Management Co Ltd 多環式化合物の製造法およびその中間体
US20110288063A1 (en) * 2010-05-19 2011-11-24 Naeja Pharmaceutical Inc. Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
CN104341345B (zh) * 2014-10-24 2016-03-23 海门海康生物医药科技有限公司 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法
WO2020179859A1 (ja) 2019-03-06 2020-09-10 第一三共株式会社 ピロロピラゾール誘導体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507521A (pt) * 1994-04-25 1997-09-16 Smithkline Beecham Plc Formulação farmacêutica método para o tratemento de infecções bacterianas em seres humanos e animais uso de uma formulação e processo para sua preparação
US20040132706A1 (en) * 2001-10-05 2004-07-08 Daniela Salvemini Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors

Also Published As

Publication number Publication date
US20060276446A1 (en) 2006-12-07
WO2007030166A2 (en) 2007-03-15
MX2007015173A (es) 2008-02-15
JP2008542376A (ja) 2008-11-27
AU2006287938A1 (en) 2007-03-15
BRPI0611491A2 (pt) 2010-12-21
CA2610478A1 (en) 2007-03-15
AR054467A1 (es) 2007-06-27
SV2007002555A (es) 2007-02-02
CN101189010A (zh) 2008-05-28
PE20070010A1 (es) 2007-01-12
WO2007030166A3 (en) 2007-05-24
EP1885358A2 (en) 2008-02-13
GT200600235A (es) 2007-03-29

Similar Documents

Publication Publication Date Title
NO20076076L (no) Bicykliske 6-alkyliden-penems som klasse-D beta-laktamase inhibitorer
UA101966C2 (xx) Інгібітори бета-лактамаз$ингибиторы бета-лактамаз
WO2007097940A3 (en) Reca inhibitors with antibiotic activity, compositions and methods of use
WO2007129176A3 (en) Improvements in therapy for treating resistant bacterial infections
EP2687533A3 (en) Acrylamide derivatives as FAB I inhibitors
WO2008127275A3 (en) Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
WO2008039420A3 (en) Novel inhibitors of beta-lactamase
GEP20094679B (en) Dipeptidyl peptidase inhibitors
NO20092433L (no) Anvendelse av beta-laktamase
WO2007067416A3 (en) Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
MY127495A (en) Dipeptide derivatives
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
TW200716104A (en) Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
WO2010021934A3 (en) Azaindole inhibitors of iap
MX2022006109A (es) Derivados 1-aminosulfonil-2-carboxipirrol como inhibidores de metalo-beta-lactamasa.
WO2003106476A8 (en) INHIBITION OF ENTEROCOCCAL INFECTION AND CYTOLYSIN ACTIVITY INDUCED BY NUCLEIC ACIDS
TW200745074A (en) New pharmaceutical compounds
WO2005041904A3 (en) Inhibitors of coronavirus protease and methods of use thereof
WO2009023160A8 (en) Novel inhibitors of bacterial sortase enzymes and methods of using the same
WO2004048393A3 (en) NOVEL INHIBITORS OF β-LACTAMASE
MX2009009074A (es) Macrolidos basados en eritromicina.
TW200621744A (en) Mercaptoamides as histone deacetylase inhibitors
MX2023004012A (es) Sintesis de derivados acidos de pirrol.
SG151171A1 (en) Association between an anti-atherothrombotic and an angiotensin- converting enzyme inhibitor
TW200727897A (en) Bicyclic 6-alkylidene-penem β-lactamase inhibitors and β-lactam antibiotic combination: a broad spectrum antibiotic